Documentos de Académico
Documentos de Profesional
Documentos de Cultura
Pangkuwidjaja P
Oxygen Transport
Ventilation
only one component of human ventilation
gases must be :
efficiently distributed to the alveoli
exchange with the pulmonary circulation
transported to and from the tissues
Oxygen Transport
Henry’s Law
the amount of oxygen that dissolves will be :
directly proportional to its solubility coefficient
inversely proportional to the temperature
Hb saturation
the proportion of available Hb that is actually
carrying oxygen
pH
Temperature
The concentration of certain organic phosphate in erythrocyte
Variation in the chemical structure of Hb
P50
Oxygen Therapy
Indications
Hypoxemia
A relative deficiency of O2 tension in the arterial blood
Cause of Hypoxia
Cause Primary Indicator Mechanism Example
Harmful Physiologic Effect of Hypoxia
Pulmonary vasoconstriction
Cardiovascular workload
Deleterious effect on myocardial function
Impaired renal function
Altered CNS function
Anaerobic metabolism, lactic acid accumulation, and metabolic acidosis
Breathing circuits
1. Rebreathing
2. Non-rebreathing
Ideal :
Should deliver any desired FiO2 under all clinical conditions
Should be comfortable for prolonged period
In clinical practice
FDO2
Stability of FiO2 under changing patient demand
Oxygen therapy systems
Patient’s flow
Device’s flow
Oxygen delivery devices
1. Low-flow system
• Nasal catheter
• Nasal cannulas
Simple available
easy to apply tolerable
inexpensive
5–6 0.40
6–7 0.50
7–8 0.60
6 0.60
7 0.70
8 0.80
9 0.80 +
10 0.80 +
• Nonrebreathing mask
3 unidirectional valves
1 valve on each side
to permit the venting of exhaled gases
to prevent RA entraiment
1 valve between the mask and reservoir bag
to prevent exhaled gases from entering the bag
• Nonrebreathing mask
• Ventury mask
Benoulli principle
Oxygen delivery devices
2. High-flow system
• Ventury mask
FiO2 varies
by altering the gas orifice or entrainment port size
fixed FiO2 model
variable FiO2 model
predictable
Independent of respiratory pattern
Monitoring Delivered Oxygen Concentration
Input
FDO2
Outcome
Physiologic result
PaO2
SaO2
‘ Three Ps ‘
Purpose
Patient
Performance
Purpose of oxygen therapy
Hypoxic symptoms
Severity/cause of hypoxia
Patient age group
Degree of consciousness/alertness
Presence / absence of a tracheal airway
Stability of the minute ventilation
Equipment performance
Vary in :
Actual FDO2
Stability of FiO2 under changing patient demands
Oxygen toxicity
Oxygen-induced hypoventilation
Retinopathy of prematurity
Absorption atelectasis
Depression of ciliary and/or leukocyte function
Altered surfactant production / activity
Oxygen toxicity
Superoxide dismutase
OXYGEN RADICALS
Glutathion peroxidase
Catalase
Superoxide anion
Hydrogen peroxide
Hydroxyl radical
ANTIOXIDANTS
Vit E
Vit C
Beta-carotene
Oxygen toxicity
Clinical picture
Diffuse bronchopneumonia
Patchy infiltrates
Increased Increased
FiO2 shunting
Low
PaO2
Factors altering development of O2 toxicity
COPD
chronic hypoxemia and hypercapnia
ventilatory drive to CO2 is blunted
ventilatory drive by low O2
• Premature
• Low birth-weigh infant
Pulmonary hypertension
Recurring congestive heart failure
Chronic cor pulmonale
Erythrocytosis
Impaired cognitive process
Nocturnal restlessness
Morning headache
Oxygen delivery devices
2. High-flow system
• Aerosol mask and T piece with nebulizer or air-oxygen blender